Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
May 7th, 2027 |
NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required) |
National Institutes of Health |
January 7th, 2026 |
Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional) |
National Institutes of Health |
July 14th, 2026 |
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required) |
National Institutes of Health |
May 26th, 2029 |
AHRQ Health Services Research Demonstration and Dissemination Grants (R18) |
Agency for Health Care Research and Quality |
July 17th, 2029 |
AHRQ Small Health Services Research Grant Program (R03) |
Agency for Health Care Research and Quality |
July 6th, 2029 |
AHRQ Health Services Research Projects (R01) |
Agency for Health Care Research and Quality |
October 4th, 2024 |
Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
October 4th, 2024 |
Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
June 13th, 2024 |
Multi-Scale Models Bridging Levels of Analysis in Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 22nd, 2024 |
USAID Strengthening Local Health Security |
USAID VIETNAM |
July 14th, 2026 |
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
October 6th, 2026 |
NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) |
National Institutes of Health |
November 13th, 2026 |
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) |
National Institutes of Health |
November 13th, 2026 |
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
National Institutes of Health |
November 13th, 2026 |
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) |
National Institutes of Health |
March 31st, 2024 |
FY2024 U.S. Consulate General Osaka-Kobe: Games for Social Change Program |
US Mission to Japan |
June 27th, 2024 |
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required) |
National Institutes of Health |
February 13th, 2024 |
Localization in Health |
Nigeria USAID Abuja |
April 24th, 2024 |
Prevention Technology Transfer Centers Cooperative Agreements |
Substance Abuse and Mental Health Services Adminis |
January 13th, 2027 |
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
National Institutes of Health |
|
August 14th, 2024 |
Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Basic Experimental Studies with Humans (BESH) Required) |
National Institutes of Health |
January 13th, 2027 |
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) |
National Institutes of Health |
August 14th, 2024 |
Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
August 14th, 2024 |
Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trial Optional) |
National Institutes of Health |
July 25th, 2024 |
Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R43/R44 Clinical Trials Not Allowed) |
National Institutes of Health |
July 25th, 2024 |
Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R41/R42 Clinical Trials Not Allowed) |
National Institutes of Health |
February 9th, 2024 |
USAID/Kenya and East Africa Global Health Security (GHS) Activity |
Kenya USAID Nairobi |
January 7th, 2027 |
Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 30th, 2024 |
Evaluation and Coordinating Center for the AHRQ/PCORI Learning Health System Embedded Scientist Training and Research Centers (U18) |
Agency for Health Care Research and Quality |
May 31st, 2024 |
Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2027 |
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
March 5th, 2024 |
Rehabilitation for Ukraine (Rehab4U) Activity |
Ukraine USAID Kiev |
March 22nd, 2024 |
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2027 |
Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed) |
National Institutes of Health |
March 9th, 2026 |
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed |
National Institutes of Health |
June 22nd, 2026 |
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) |
National Institutes of Health |
June 25th, 2026 |
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) |
National Institutes of Health |
June 22nd, 2026 |
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) |
National Institutes of Health |
June 22nd, 2026 |
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) |
National Institutes of Health |
February 22nd, 2024 |
Regional Approaches for Eradicating Tuberculosis (RAFET) |
Kazakhstan USAID Almaty |